Vishnu Chemicals Ltd Q2 FY2025 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/gfhy5dg9szn0rvj4n8a1w9nw.pdf

Key Takeaways


Margin Walk: The Raw Material Shock

Hanumant Bhansali: "The EBITDA margins for the subsidiary business is expected to improve and from the current levels of around 16.75%, we expect it to increase over the next two quarters by 100 to 200 basis points."

Barium: The Standout Performer

Siddartha Cherukuri: "We are planning to double the capacity by FY '27 of Precipitated Barium Sulfate. Currently which we are seeing is 30,000 tons considering operating level of 80% to 90%. We will have to take it up to 60,000 tons considering the operating level of 80%."

Strategic Acquisitions: The Mine and the New Molecule

Siddartha Cherukuri: "It's a complete import substitute. Right now there is no other player that's producing this in India."

Demand and Logistics: Managing the Export Drag


New Products and the Growth Algorithm

Siddartha Cherukuri: "Our objective is to grow at least at a 20% level year-on-year. Maybe in certain challenging years like this, we have to revise our guidance, but I think our idea is to grow and be sustainable as we move forward."

Guidance & Commitments

CommitmentSpecificsTimeline
Barium EBITDA margin expansionIncrease by 100 to 200 bps from current ~16.75%Next two quarters
PBS volume growthClose to 40% for FY25 vs FY24FY25
PBS capacity doublingFrom 30,000 tons to at least 50,000 tons (at 80% operating level)By FY27
Chrome mine commercial productionPartially operating, feeding sizable volumeH2 FY26
Chrome mine full self-sufficiency100% of chrome ore requirement sourced internallyEnd-FY26 to H1 FY27
Chrome mine margin impactImprove consolidated EBITDA margins by at least 2% to 3%At full operating level
Chromium metal launchNew value-added productQ1 FY26
Strontium Carbonate production startVia Jayansree Pharma acquisitionQ1 FY26
Strontium Carbonate revenue₹140 to ₹150 croreAt full 10,000-ton operating level, two years down the line
Chromite ore cost reliefLower ore price to reflect in P&LQ4 FY25
High-cost chrome ore inventory spilloverWill not extend beyond Q3Q3 FY25

Key Metrics

MetricQ2 FY25
Consolidated operating revenue₹343.8 cr, +12% YoY
Consolidated gross profit₹147 cr, +6% YoY
Consolidated EBITDA₹45.1 cr, -2% YoY
Consolidated PAT₹22.8 cr, -5% YoY
H1 FY25 consolidated operating revenue₹682.7 cr, +12% YoY
H1 FY25 consolidated EBITDA₹100.8 cr, +4% YoY
H1 FY25 consolidated PAT₹53.3 cr, +1% YoY
Domestic-to-export sales mix57:43, driven by robust domestic demand
Consolidated debt-to-equity ratio0.45x
Barium business EBITDA margin>16.75% in Q2 FY25, expected to improve 100–200 bps over next two quarters
Precipitated Barium Sulfate volume growth guidance~40% for FY25 vs FY24
Precipitated Barium Sulfate plant utilization65%–70%, de-bottlenecking underway to reach 80%–90%
Chromium chemicals capacity80,000 tons per annum (Sodium dichromate basis)
Barium chemicals total capacity~90,000 tons per annum (Barium Carbonate 60,000 tons, Precipitated Barium Sulfate 30,000 tons)
Chromium chemicals market share in India~50%
Precipitated Barium Sulfate market share in India~30%, expanded from ~15% last year; sole manufacturer in India
Scheduled maintenance shutdown22 days in Q2, 8 days remaining over FY25
Chrome mine acquisition expected EBITDA margin uplift2%–3% at full operating level
Jayansree Pharma enterprise value₹51.99 cr, gross block ~₹80 cr, net block >₹50 cr
Strontium Carbonate peak revenue potential₹140–150 cr at full 10,000-ton operating level, two years out